rss
Evid Based Nurs 12:26 doi:10.1136/ebn.12.1.26
  • Prognosis

Excess mortality after HIV seroconversion has greatly decreased in the past 10 years

K Porter

Dr K Porter, MRC Clinical Trials Unit, London, UK; kp@ctu.mrc.ac.uk

QUESTIONS

What is the risk of death in HIV-infected people compared with the general population? Has this risk changed since the introduction of highly active antiretroviral therapy (HAART)?

METHODS

Design:

inception cohort followed up for a median 6.3 years.

Setting:

10 European countries, Australia, and Canada.

Patients:

16 534 patients ⩾15 years of age at HIV seroconversion (median age 29 y, 78% men) who had well-estimated dates of seroconversion (within 18 mo) and exposure to HIV through injection drug use (18% of patients), sex between men (57%), or heterosexual sex (24%).

Prognostic factors:

calendar period of follow-up (before 1996, 1996–7, 1998–9, 2000–1, 2002–3, and 2004–6), sex, age at seroconversion, and HIV exposure category.

Outcomes:

mortality, excess …

No Related Web Pages

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>

EBN Journal Chat

The EBN Journal Chat offers readers the opportunity to participate in discussion about research articles and commentaries from Evidence Based Nursing (EBN).

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article